A supplement to Ob.Gyn. News.
Supported by an educational grant from Gynecare Worldwide, a division of Ethicon, Inc., a Johnson & Johnson Company.
The articles in this supplement are based on clinical dialogues with the faculty.
•Contents
•Faculty/Faculty Disclosure Statement
To view the supplement, click the image above.
Contents
Introduction
Consequences of Heavy Menstrual Bleeding
Types, Patterns, and Causes of Abnormal Uterine Bleeding
• Evaluating the Endometrial Cavity
Treatment Options: Entering the Dialogue
• Medical Therapy
• Surgical Interventions
• Endometrial Ablation Procedures
Considering Cases:
• An Overweight Patient
• A Patient Who Prefers to Avoid Hysterectomy
• A Patient With Postsurgical HMB
Helping Patients Choose
Faculty/Faculty Disclosure Statement
Mary Jane Minkin, MD, FACOG, Chair
Clinical Professor
Department of Obstetrics and Gynecology
Yale University School of Medicine
New Haven, Conn.
Developed a Web site for Gynecare; Speaker's Bureau: Berlex, Inc.
Charles E. Miller, MD, FACOG
Clinical Associate Professor
Department of Obstetrics and Gynecology
University of Illinois at Chicago
Clinical Associate
Department of Obstetrics and Gynecology
University of Chicago
Consultant: Gynecare Worldwide.
Malcolm G. Munro, MD, FRCS(c), FACOG
Professor
Department of Obstetrics and Gynecology
The David Geffen School of Medicine at UCLA
Los Angeles
Attending Staff
Department of Obstetrics and Gynecology
Kaiser Permanente Los Angeles Medical Center
Received Funding for Clinical Grants: Kaiser Research Foundation and Karl Storz Endoscopy-America, Inc.M
Consultant: Boston Scientific Corporation, Gynecare, and Karl Storz Endoscopy.
Robert K. Zurawin, MD, FACOG
Associate Professor
Department of Obstetrics and Gynecology
Baylor College of Medicine
Houston
Consultant/Speaker: Gynecare Worldwide.
Copyright © 2004 by International Medical News Group